MSX1 inhibits cell migration and invasion through regulating the Wnt/β-catenin pathway in glioblastoma

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cancer Genetics

Background:

• Glioblastoma is an aggressive primary brain tumor with a poor prognosis.
• Tumor cell invasion is a critical factor in glioblastoma progression and treatment resistance.
• Understanding the molecular drivers of glioblastoma invasion is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the role of the homeobox transcription factor MSX1 in glioblastoma.
• To determine the relationship between MSX1 expression levels and patient survival.
• To elucidate the molecular mechanisms by which MSX1 regulates glioblastoma cell invasion.

Main Methods:

• Quantitative analysis of MSX1 expression in glioblastoma tissues versus normal brain tissues.
• Correlation analysis between MSX1 levels and patient survival data.
• In vitro studies using cultured glioblastoma cells to assess the effects of MSX1 modulation on cell migration, invasion, and epithelial-mesenchymal transition (EMT).
• Investigation of MSX1's impact on the Wnt/β-catenin signaling pathway.

Main Results:

• MSX1 expression is significantly reduced in glioblastoma tissues compared to normal brain.
• Lower MSX1 levels correlate with reduced patient survival.
• MSX1 acts as a negative regulator of glioblastoma cell migration and invasion.
• Loss of MSX1 promotes EMT, evidenced by altered E-cadherin and N-cadherin expression.
• MSX1 overexpression inhibits cell migration, invasion, and EMT.
• MSX1 suppresses glioblastoma cell invasion by inhibiting the Wnt/β-catenin signaling pathway.

Conclusions:

• MSX1 plays a critical role in suppressing glioblastoma cell invasion and metastasis.
• Reduced MSX1 expression is linked to poor prognosis in glioblastoma patients.
• Targeting MSX1 or its downstream pathways may represent a novel therapeutic strategy for glioblastoma.